Wnt signaling inhibitor comprising insulin-like growth factor-binding protein

摘要

Provided is a novel soluble factor that modulates morphogenesis and cell proliferation, such as cardiac development and/or cardiomyocyte differentiation. Specifically provided are: an inhibitor of Wnt signalling, comprising an insulin-like growth-factor-binding protein (IGFBP), the protein being binding to a Wnt receptor, and/or a polynucleotide encoding the protein; a medicament for prevention and/or treatment of a disease due to enhanced Wnt signalling, comprising the inhibitor of Wnt signalling, and a medicament for induction of cardiomyocyte differentiation; and a method for prevention and/or treatment of a disease due to enhanced Wnt signalling and a method of inducing cardiomyocyte differentiation, the methods each comprising using the inhibitor of Wnt signalling, and a cardiomyocyte, which is obtained by the method of inducing cardiomyocyte differentiation, and a use thereof.

主权项

1. A method of inhibiting Wnt signalling, comprising contacting an insulin-like growth-factor-binding protein (IGFBP) with a Wnt receptor in vitro, wherein the insulin-like growth-factor-binding protein (IGFBP) is a protein represented by an amino acid sequence set forth in SEQ ID NO: 2 of Sequence Listing.